©2015 Bloomberg News NSCTMP6K50Y3 (Bloomberg) — Merck & Co.’s vaccine for Ebola is “highly effective,” according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue. The vaccine was 100 percent effective when it was tested on more than 4,000 people who were

published Sep 5, 2017 5:30:01 PM, by Bloomberg News (Bloomberg) — President Donald Trump’s rhetoric about imposing widespread sanctions on China for propping up North Korea’s economy may put pressure on some of its banks and oil companies. Harsh critics of China’s support for its neighbor have argued that American